ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T)

Home
4886.T
Financials

2153 (JPY) • At close September 18, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1	2015 Q4	2015 Q3	2015 Q2	2015 Q1	2014 Q4	2014 Q3	2014 Q2	2014 Q1	2013 Q4	2013 Q3	2013 Q2	2013 Q1	2012 Q4	2012 Q3	2012 Q2
Revenue Numbers are in millions	16,352	14,019	17,176	15,625	16,023	13,202	17,087	14,903	15,269	12,428	15,702	14,256	14,221	11,831	15,947	13,689	13,714	11,335	14,625	12,591	13,991	9,690	13,539	10,716	12,761	10,231	13,659	12,241	12,813	11,052	13,159	12,329	11,987	9,683	12,425	10,384	10,723	9,189	10,523	12,762	10,433	8,617	10,858	9,485	10,541	9,748	11,077	9,832
Cost of Revenue Numbers are in millions	8,181	6,985	8,732	7,902	8,559	6,983	9,023	7,853	8,017	6,770	8,434	7,520	7,531	6,775	8,460	6,923	7,640	5,882	8,151	7,131	7,361	5,783	8,002	6,574	7,456	6,708	8,120	7,481	7,750	6,542	8,046	7,521	7,505	6,240	7,101	6,338	6,392	5,271	6,063	8,282	6,098	5,339	5,826	5,500	5,766	5,493	6,233	5,594
Gross Profit Numbers are in millions	8,171	7,034	8,444	7,723	7,464	6,219	8,064	7,050	7,252	5,658	7,268	6,736	6,690	5,056	7,487	6,766	6,074	5,453	6,474	5,460	6,630	3,907	5,537	4,142	5,305	3,523	5,539	4,760	5,063	4,510	5,113	4,808	4,482	3,443	5,324	4,046	4,331	3,918	4,460	4,480	4,335	3,278	5,032	3,985	4,775	4,255	4,844	4,238
Gross Profit Ratio Numbers are in millions	0.5	0.502	0.492	0.494	0.466	0.471	0.472	0.473	0.475	0.455	0.463	0.473	0.47	0.427	0.469	0.494	0.443	0.481	0.443	0.434	0.474	0.403	0.409	0.387	0.416	0.344	0.406	0.389	0.395	0.408	0.389	0.39	0.374	0.356	0.428	0.39	0.404	0.426	0.424	0.351	0.416	0.38	0.463	0.42	0.453	0.436	0.437	0.431
Reseach & Development Expenses Numbers are in millions	1,652	1,299	1,019	1,469	941	1,361	1,098	917	851	990	667	887	1,054	0	0	0	0	4,913	0	0	0	4,493	0	0	0	4,055	0	0	0	4,970	0	0	0	4,174	0	0	0	4,025	0	0	0	4,144	0	0	0	4,269	0	0
General & Administrative Expenses Numbers are in millions	0	-1,544	0	0	0	-1,297	0	0	0	-1,218	0	0	0	0	0	0	0	-5,440	0	0	0	-675	0	0	0	-860	0	0	0	-736	0	0	0	-679	0	0	0	-690	0	0	0	-988	0	0	0	-867	0	0
Selling & Marketing Expenses Numbers are in millions	0	6,305	0	0	0	6,088	0	0	0	5,767	0	0	0	0	0	0	0	5,993	0	0	0	885	0	0	0	963	0	0	0	1,013	0	0	0	1,021	0	0	0	1,050	0	0	0	1,098	0	0	0	1,255	0	0
SG&A Numbers are in millions	4,761	4,761	4,955	4,902	5,759	4,791	4,804	4,918	4,736	4,549	4,582	4,380	4,447	5,223	5,656	5,719	5,175	553	5,700	5,552	5,791	210	3,918	4,400	4,086	103	3,953	3,963	3,986	277	4,470	3,937	4,019	342	4,275	3,774	4,097	360	3,639	3,754	3,989	110	4,051	4,059	3,989	388	4,019	4,187
Other Expenses Numbers are in millions	0	23	-60	-66	-62	21	-37	-48	-3	21	-21	-35	-38	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	6,413	6,060	5,974	6,371	5,759	6,152	5,902	5,835	5,587	5,539	5,249	5,267	5,501	5,223	6,296	5,793	5,198	6,189	5,824	5,437	5,830	4,718	3,788	4,619	4,063	4,152	3,920	3,940	3,985	5,928	1,916	3,987	4,011	3,776	4,321	3,736	4,048	4,328	3,598	3,788	3,941	4,288	3,991	4,037	3,959	4,713	3,973	3,801
Operating Income Numbers are in millions	1,758	974	2,471	1,351	1,704	67	2,162	1,215	1,664	118	2,020	1,469	1,188	-167	1,831	1,047	899	-13	774	-92	839	-796	1,619	-258	1,219	-635	1,586	797	1,077	-183	643	871	463	-389	1,049	272	234	-482	821	726	346	-991	981	-74	786	-417	825	54
Operating Income Ratio Numbers are in millions	0.108	0.069	0.144	0.086	0.106	0.005	0.127	0.082	0.109	0.009	0.129	0.103	0.084	-0.014	0.115	0.076	0.066	-0.001	0.053	-0.007	0.06	-0.082	0.12	-0.024	0.096	-0.062	0.116	0.065	0.084	-0.017	0.049	0.071	0.039	-0.04	0.084	0.026	0.022	-0.052	0.078	0.057	0.033	-0.115	0.09	-0.008	0.075	-0.043	0.074	0.005
Total Other Income Expenses Net Numbers are in millions	55	368	639	2,186	167	-77	186	-1	141	196	7,968	-6,937	141	-32	-556	-82	88	-733	-45	103	68	-23	209	-224	136	8	110	24	95	-1,269	2,654	-10	131	78	22	49	132	85	103	-35	124	-11	126	38	91	-42	95	389
Income Before Tax Numbers are in millions	1,813	1,342	3,110	3,537	1,873	-10	2,348	1,214	1,805	314	9,988	-5,468	1,329	348	1,275	965	987	-746	729	11	907	-819	1,828	-482	1,355	-627	1,696	821	1,172	-1,452	3,297	861	594	-311	1,071	321	366	-397	924	691	470	-1,002	1,107	-36	877	-459	920	443
Income Before Tax Ratio Numbers are in millions	0.111	0.096	0.181	0.226	0.117	-0.001	0.137	0.081	0.118	0.025	0.636	-0.384	0.093	0.029	0.08	0.07	0.072	-0.066	0.05	0.001	0.065	-0.085	0.135	-0.045	0.106	-0.061	0.124	0.067	0.091	-0.131	0.251	0.07	0.05	-0.032	0.086	0.031	0.034	-0.043	0.088	0.054	0.045	-0.116	0.102	-0.004	0.083	-0.047	0.083	0.045
Income Tax Expense Numbers are in millions	539	254	782	836	444	-66	511	191	482	107	3,108	-1,572	230	85	376	152	248	331	242	3	344	347	355	163	293	11	313	221	129	486	662	112	68	112	363	92	179	15	264	138	143	207	326	68	370	167	260	112
Net Income Numbers are in millions	1,273	1,087	2,329	2,701	1,428	55	1,837	1,023	1,323	208	6,878	-3,894	1,098	262	899	813	739	-415	487	14	563	-472	1,473	-319	1,062	-638	1,383	600	1,043	-966	2,635	749	526	-379	685	208	187	-288	645	541	295	-786	759	14	508	-281	655	329
Net Income Ratio Numbers are in millions	0.078	0.078	0.136	0.173	0.089	0.004	0.108	0.069	0.087	0.017	0.438	-0.273	0.077	0.022	0.056	0.059	0.054	-0.037	0.033	0.001	0.04	-0.049	0.109	-0.03	0.083	-0.062	0.101	0.049	0.081	-0.087	0.2	0.061	0.044	-0.039	0.055	0.02	0.017	-0.031	0.061	0.042	0.028	-0.091	0.07	0.001	0.048	-0.029	0.059	0.033
EPS Numbers are in millions	44.94	38.37	82.21	95.41	50.48	1.94	64.97	36.25	46.94	5.81	242.28	-137.17	38.72	9.23	31.7	28.68	26.08	-14.65	17.2	0.5	19.93	-16.72	52.17	-11.3	37.67	-22.63	49.07	21.29	37.08	-34.56	94.3	26.81	18.83	-13.57	24.55	7.46	6.71	-10.34	23.17	19.44	10.61	-28.27	27.32	0.5	18.31	-10.14	23.66	11.9
EPS Diluted Numbers are in millions	44.94	38.37	82.21	95.41	50.48	1.94	64.97	36.23	46.94	5.81	242.25	-137.01	38.72	9.23	31.7	28.68	26.08	-14.65	17.2	0.5	19.93	-16.72	52.17	-11.3	37.67	-22.63	49.07	21.29	37.08	-34.56	94.3	26.81	18.83	-13.57	24.55	7.46	6.71	-10.34	23.17	19.44	10.61	-28.27	27.32	0.5	18.31	-10.14	23.66	11.9
EBITDA Numbers are in millions	2,257	1,545	2,545	1,297	1,820	51	2,272	1,226	1,818	146	2,060	-5,453	1,343	646	2,771.25	1,945.5	1,839.25	927.25	1,428.5	802	1,493.5	-141.5	2,217.5	321.5	1,817.5	-36.5	2,211.25	1,368	1,702.25	442.25	1,157.25	1,458	977.25	125.25	1,502.75	648.5	687.75	-28.25	1,435.75	1,159.5	960.75	-376.25	1,589.5	485	1,394.5	191.5	1,519.5	630.5
EBITDA Ratio Numbers are in millions	0.138	0.11	0.148	0.083	0.114	0.004	0.133	0.082	0.119	0.012	0.131	-0.383	0.094	0.055	0.174	0.142	0.134	0.082	0.098	0.064	0.107	-0.015	0.164	0.03	0.142	-0.004	0.162	0.112	0.133	0.04	0.088	0.118	0.082	0.013	0.121	0.062	0.064	-0.003	0.136	0.091	0.092	-0.044	0.146	0.051	0.132	0.02	0.137	0.064

ASKA Pharmaceutical Holdings Co.,Ltd.

TSE:4886.T Add to watchlist

TSE:4886.T